OGN - Organon & Co.
6.87
-0.030 -0.437%
Share volume: 3,152,077
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$6.90
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-28-2025 | 05-02-2025 | 11-10-2025 | 02-24-2026 | |
| Cash flow financing | -82.000 M | -75.000 M | -76.000 M | -187.000 M | |
| Other financing cash flows | -4.000 M | -1.000 M | -1.000 M | -1.000 M | |
| Cash flow | 12.000 M | -172.000 M | 73.000 M | -111.000 M | |
| Net income | 109.000 M | 87.000 M | 160.000 M | -205.000 M | |
| Depreciation | 34.000 M | 34.000 M | 40.000 M | 46.000 M | |
| Changes in inventories | 0.000 | -3.000 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -296.000 M | -172.000 M | -115.000 M | -65.000 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | -74.000 M | -71.000 M | -3.000 M | -4.000 M | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 53.000 M | 32.000 M | 46.000 M | 45.000 M | |
| Cash Change | -88.000 M | -128.000 M | 73.000 M | -98.000 M |